Form 8-K - Current report:
SEC Accession No. 0001023024-04-000005
Filing Date
2004-12-16
Accepted
2004-12-16 16:00:08
Documents
1
Period of Report
2004-12-14
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 TERMINATION OF COMPENSATION PLAN compplantermination.htm 8-K 21033
  Complete submission text file 0001023024-04-000005.txt   22737
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 041208369
SIC: 2836 Biological Products, (No Diagnostic Substances)